AI is Eating Drug Discovery: A Glance at Some Menus

Two recently published lists reveal just how many drug discovery startups and established pharma firms are using AI; there are hundreds and the list continues to grow.
Published in Protocols & Methods
AI is Eating Drug Discovery: A Glance at Some Menus
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

In the early 2010s, prominent software executive and investor Marc Andreessen famously wrote that "software is eating the world." In the early 2020s, one can easily extend that idea to the application of artificial intelligence (AI) in the realm of drug discovery. A 2018 report looked at how AI was impacting essentially all aspects of drug discovery from mechanism of action to clinical trials.

Now, two recent lists have attempted to survey this exploding field of companies using AI for drug discovery:

186 Startups Using Artificial Intelligence in Drug Discovery arranges the various startups according to application area (e.g., establishing biomarkers, design drugs, clinical trial recruiting, etc.).

40 Pharma Companies Using Artificial Intelligence in Drug Discovery follows up on the above list and focuses heavily on established pharma companies like Bristol-Meyers Squibb, Genentech, and Takeda.

Taken together, these two lists give a great overview of "who's doing what and where". For even more information and suggestions, do have a look at the comments sections of both lists!

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in